Patents Assigned to CREATION PLUS BIOTECHNOLOGY CO. LTD
  • Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine
    Patent number: 10851136
    Abstract: The present invention relates to an oral universal influenza vaccine comprising recombinant lactic acid bacteria which express proteins including but not limited to ferritin protein plus highly-conserved stem fragment of hemagglutinin (HA) proteins expressed in all known influenza viruses. The present invention also relates to the recombinant protein comprising the highly-conserved stem fragment of HA and ferritin proteins.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: December 1, 2020
    Assignee: CREATION PLUS BIOTECHNOLOGY CO. LTD
    Inventors: Chung Yan Shum, Tak Keung Andy Wong